CR8577A - Derivados de coumarina y su uso - Google Patents
Derivados de coumarina y su usoInfo
- Publication number
- CR8577A CR8577A CR8577A CR8577A CR8577A CR 8577 A CR8577 A CR 8577A CR 8577 A CR8577 A CR 8577A CR 8577 A CR8577 A CR 8577A CR 8577 A CR8577 A CR 8577A
- Authority
- CR
- Costa Rica
- Prior art keywords
- optionally substituted
- ring
- hydrocarbon group
- carboxyl group
- linear
- Prior art date
Links
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical class C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title 1
- -1 alkaline earth metal salt Chemical class 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion se refiere a una sal de metal alcalinoterrea o una sal de amina organica de un compuesto representando por la formula (I): en donde R1 y R2 son cada uno un atomo de hidrogeno , un atomo de halogeno, o un grupo hidrocarburo lineal opcionalmente substituido ; el anillo A es un anillo benceno opcionalmente ademas substituido, el anillo B es un anillo benceno opcionalmente substituido; R es un grupo carboxilo o un grupo hidrocarburo lineal con un grupo carboxilo y similares.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004057920 | 2004-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR8577A true CR8577A (es) | 2007-01-17 |
Family
ID=34909071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR8577A CR8577A (es) | 2004-03-02 | 2006-08-29 | Derivados de coumarina y su uso |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7541478B2 (es) |
| EP (1) | EP1720850A1 (es) |
| JP (1) | JP2007526237A (es) |
| KR (1) | KR20060130189A (es) |
| CN (1) | CN1950352A (es) |
| AU (1) | AU2005217335A1 (es) |
| BR (1) | BRPI0508260A (es) |
| CA (1) | CA2557162A1 (es) |
| CR (1) | CR8577A (es) |
| IL (1) | IL177105A0 (es) |
| NO (1) | NO20064398L (es) |
| RU (1) | RU2006134614A (es) |
| TW (1) | TW200531969A (es) |
| UA (1) | UA84052C2 (es) |
| WO (1) | WO2005082879A1 (es) |
| ZA (1) | ZA200606598B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2920774B1 (fr) * | 2007-09-06 | 2009-10-30 | Galderma Res & Dev | Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant |
| CN103833713B (zh) * | 2008-11-28 | 2016-02-03 | 中国医学科学院药物研究所 | 硝克柳胺化合物晶iii型、其制法和其药物组合物与用途 |
| CN109111478B (zh) * | 2017-06-26 | 2021-02-26 | 上海日馨生物科技有限公司 | 苯磷硫胺衍生物、制备方法及其药物组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO179904C (no) * | 1992-09-04 | 1997-01-08 | Takeda Chemical Industries Ltd | Kondenserte heterocykliske forbindelser og deres anvendelse |
| EP1302470A4 (en) * | 2000-07-13 | 2005-04-06 | Takeda Pharmaceutical | INHIBITORS OF PLATES RICH IN LIPID |
| JP2002255808A (ja) | 2000-07-13 | 2002-09-11 | Takeda Chem Ind Ltd | リピド・リッチ・プラーク退縮剤 |
| IL162810A0 (en) * | 2002-01-11 | 2005-11-20 | Takeda Pharmaceutical | coumarin derivatives, process for their productionand use thereof |
-
2005
- 2005-03-01 JP JP2006527190A patent/JP2007526237A/ja not_active Withdrawn
- 2005-03-01 US US10/591,561 patent/US7541478B2/en not_active Expired - Fee Related
- 2005-03-01 WO PCT/JP2005/003838 patent/WO2005082879A1/en not_active Ceased
- 2005-03-01 CN CNA2005800141422A patent/CN1950352A/zh active Pending
- 2005-03-01 EP EP05720110A patent/EP1720850A1/en not_active Withdrawn
- 2005-03-01 RU RU2006134614/04A patent/RU2006134614A/ru not_active Application Discontinuation
- 2005-03-01 KR KR1020067017614A patent/KR20060130189A/ko not_active Withdrawn
- 2005-03-01 TW TW094106014A patent/TW200531969A/zh unknown
- 2005-03-01 AU AU2005217335A patent/AU2005217335A1/en not_active Abandoned
- 2005-03-01 CA CA002557162A patent/CA2557162A1/en not_active Abandoned
- 2005-03-01 BR BRPI0508260-9A patent/BRPI0508260A/pt not_active IP Right Cessation
- 2005-03-01 UA UAA200609517A patent/UA84052C2/ru unknown
- 2005-03-01 ZA ZA200606598A patent/ZA200606598B/xx unknown
-
2006
- 2006-07-26 IL IL177105A patent/IL177105A0/en unknown
- 2006-08-29 CR CR8577A patent/CR8577A/es not_active Application Discontinuation
- 2006-09-28 NO NO20064398A patent/NO20064398L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2006134614A (ru) | 2008-04-10 |
| WO2005082879A1 (en) | 2005-09-09 |
| US20070197636A1 (en) | 2007-08-23 |
| KR20060130189A (ko) | 2006-12-18 |
| CN1950352A (zh) | 2007-04-18 |
| UA84052C2 (ru) | 2008-09-10 |
| NO20064398L (no) | 2006-11-08 |
| JP2007526237A (ja) | 2007-09-13 |
| EP1720850A1 (en) | 2006-11-15 |
| US7541478B2 (en) | 2009-06-02 |
| TW200531969A (en) | 2005-10-01 |
| AU2005217335A1 (en) | 2005-09-09 |
| ZA200606598B (en) | 2008-02-27 |
| BRPI0508260A (pt) | 2007-07-31 |
| IL177105A0 (en) | 2006-12-10 |
| CA2557162A1 (en) | 2005-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034985A1 (es) | Compuesto biciclico; produccion y uso del mismo | |
| UY30499A1 (es) | Derivados de amina utiles como agentes anticancerigenos | |
| UY31604A1 (es) | Compuestos tricíclicos y uso de los mismos | |
| CR10784A (es) | Nuevos derivados de aminopirimidina como inhibidores de plki | |
| PE20061297A1 (es) | Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c | |
| CO6321130A2 (es) | Piridinas carboxamidas como inhibidores de la 11 beta-hsd1 | |
| AR075084A1 (es) | Metodo de preparacion de quinolinil -oxidifenil - ciclopropanodicarboxamidas e intermediarios correspondientes | |
| CY1120477T1 (el) | Ενεργοποιητης του υποδοχεα που ενεργοποιειται απο πολλαπλασιαστες των υπεροξεισωματων | |
| MX2013006847A (es) | Compuesto heterociclico fusionado y su uso para el control de plagas. | |
| ES2422299T3 (es) | Indoles (4,5-dihidro) indoles tricíclicos | |
| PE20130375A1 (es) | Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos | |
| AR057914A1 (es) | Compuestos organicos de azufre y su uso | |
| CO6150142A2 (es) | Bezoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus | |
| EA202190654A1 (ru) | Гетероциклическое соединение | |
| AR068366A1 (es) | N-alquil-2-alquiltio-2-(heteroariloxi sustituido)-alquilamidas con actividad fungicida | |
| ECSP055974A (es) | Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas | |
| AR064521A1 (es) | Activador de glucoquinasa | |
| UY31014A1 (es) | Derivados de ftalazinona | |
| CO6170356A2 (es) | Derivados de piridazina | |
| AR058562A1 (es) | Derivados de pirimido [4,5 b] (1,4) oxazinas , procedimientos de obtencion y su uso como inhibidores de acetil coa y dgat 1 | |
| MX2009007954A (es) | Derivado de heterocicliden-n-(aril) acetamida. | |
| BR112014011064A2 (pt) | derivados de antibióticos 2-oxo-oxazolidin-3,5-diila | |
| AR077176A1 (es) | Derivado de piridina que contiene un anillo ((fosfonooxi) metil) piridinio y agente antifungico que contiene este derivado | |
| AR066603A1 (es) | Derivados de arilamida pirimidona | |
| AR064369A1 (es) | Compuestos derivados de piperidina o sales aceptables para uso farmaceutico de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |